Biotech Values

[jq1234]

I agree with your sentiment that financial term is fine but BAX isn't that good a partner. I did think outside of NVS, MNTA would have to get a non-traditional partner unlike PFE/SNY because of the non-traditional approach to biosimilar/biogenetic by MNTA.